|
|
| Line 28: |
Line 28: |
| *;'''Type 5b'''': Definite fatal bleeding; overt bleeding or autopsy or imaging confirmation }} | | *;'''Type 5b'''': Definite fatal bleeding; overt bleeding or autopsy or imaging confirmation }} |
| == References == | | == References == |
| {{Reflist}} | | {{Reflist|2}} |
| | |
| <br>
| |
|
| |
|
| [[Category:Medical emergencies]] | | [[Category:Medical emergencies]] |
| Line 36: |
Line 34: |
| [[Category:Hematology]] | | [[Category:Hematology]] |
| [[Category:Cardiology]] | | [[Category:Cardiology]] |
|
| |
| [[bg:Кръвоизлив]]
| |
| [[bs:Krvarenje]]
| |
| [[ca:Hemorràgia]]
| |
| [[cs:Krvácení]]
| |
| [[de:Blutung]]
| |
| [[es:Hemorragia]]
| |
| [[eu:Odoljario]]
| |
| [[fr:Hémorragie]]
| |
| [[it:Emorragia]]
| |
| [[he:דימום]]
| |
| [[la:Haemorrhagia]]
| |
| [[lt:Kraujavimas]]
| |
| [[nl:Versterkte bloedingsneiging]]
| |
| [[ja:出血]]
| |
| [[pl:Krwotok]]
| |
| [[pt:Hemorragia]]
| |
| [[ro:Hemoragie]]
| |
| [[qu:Yawar apariy]]
| |
| [[ru:Кровотечение]]
| |
| [[sv:Blödning]]
| |
|
| |
|
| {{WH}} | | {{WH}} |
| {{WS}} | | {{WS}} |
Revision as of 03:18, 8 August 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
in order to harmonize and create a universal definition of bleeding, the Bleeding Academic Research Consortium (BARC) was convened. Dr. C Michael Gibson chaired the subcommittee drafting the definition of bleeding types 0, 1 and 2; Dr. Gabriel Stegg chaired the subcommittee drafting the definition of bleeding types 3a and 3b; Dr. Harvey White chaired the subcommittee drafting the definitions of coronary artery bypass grafting bleeding; and Dr. Deepak Bhatt chaired the subcommittee on fetal bleeding.
Definitions
Bleeding Academic Research Consortium (BARC) definition for Bleeding (DONOT EDIT)[1]
| “
|
- Type 1: bleeding that is not actionable and does not cause the patient to seek unscheduled performance of studies, hospitalization, or treatment by a health-care professional; may include episodes leading to self-discontinuation of medical therapy by the patient without consulting a health-care professional.
- Type 2: any overt, actionable sign of hemorrhage (eg, more bleeding than would be expected for a clinical circumstance, including bleeding found by imaging alone) that does not fit the criteria for type 3, 4, or 5 but does meet at least one of the following criteria: (1) requiring nonsurgical, medical intervention by a health-care professional, (2) leading to hospitalization or increased level of care, or (3) prompting evaluation
- Type 3
- Type 3a'
- Overt bleeding plus hemoglobin drop of 3 to < 5 g/dL* (provided hemoglobin drop is related to bleed)Any transfusion with overt bleeding
- Type 3b'
- Overt bleeding plus hemoglobin drop ≥5 g/dL* (provided hemoglobin drop is related to bleed)Cardiac tamponade, Bleeding requiring surgical intervention for control (excludingdental/nasal/skin/hemorrhoid), Bleeding requiring intravenous vasoactive agents
- Type 3c'
- Intracranial hemorrhage (does not include microbleeds or hemorrhagic transformation, does include intraspinal), Subcategories confirmed by autopsy or imaging or lumbar puncture, Intraocular bleed compromising vision.
- Type 4: CABG-related bleeding, Perioperative intracranial bleeding within 48 h, Reoperation after closure of sternotomy for the purpose of controlling bleeding
Transfusion of ≥ 5 U whole blood or packed red blood cells within a 48-h period, Chest tube output more than or equal to 2L within a 24-h period
- Type 5: fatal bleeding
- Type 5a'
- Probable fatal bleeding; no autopsy or imaging confirmation but clinically suspicious
- Type 5b'
- Definite fatal bleeding; overt bleeding or autopsy or imaging confirmation
|
”
|
References
Template:WH
Template:WS